DL

Lesson 3 of 5 · 22 min

Lamotrigine: Bipolar Depression Prevention & Rash Risk

Learning objectives

  • Explain the slow titration rationale
  • Identify SJS/TEN warning signs
  • Adjust titration with interacting drugs

Lamotrigine is used for maintenance treatment of bipolar I disorder, with its strongest effect on preventing depressive episodes. It is not used for acute mania.

Its boxed warning is serious rash, including Stevens–Johnson syndrome and toxic epidermal necrolysis. Risk is higher with rapid titration, exceeding recommended starting doses, and co-administration with valproate.

If doses are missed for about five half-lives or more, re-titration from the starting dose is generally recommended rather than resuming the prior dose.

Key points

  • Slow titration over weeks
  • Best for preventing bipolar depression
  • Few metabolic side effects; weight-neutral

Exam pearls

  • ◆ Valproate ↑ lamotrigine (halve dose); carbamazepine ↓ lamotrigine
  • ◆ Any rash: evaluate promptly; stop if not clearly benign
  • ◆ Estrogen-containing contraceptives can lower lamotrigine levels

Educational content for exam preparation; verify dosing and monitoring with current prescribing information. References: [APA 7 placeholder — to be supplied by author].

Lesson check

Question 1 · lamotrigine

Lamotrigine is being added for a patient already taking valproate. What adjustment is appropriate?

Question 2 · lamotrigine

Lamotrigine is MOST effective for which phase of bipolar I disorder?

Built by Future4000